Centre for Addiction and Mental Health: all 339 studies

Page 1 of 4. Open to participants first (51), then studies with results posted, then the rest; newest registration first within each.

• Remote Digital Assessments for Cognitive DisordersNot yet recruitingNCT07883746
• Identifying Biomarkers of Response to Digital Interventions for Mood DisordersEnrolling by invitationNCT07783633Not applicable
• Group Dialectical Behaviour Therapy (DBT) Skills Training for First Episode PsychosisNot yet recruitingNCT07777315Not applicable
• Cohort Network for Adolescents and Youth With multipLe Mental Health ConditionsRecruitingNCT07699159
• Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use DisorderNot yet recruitingNCT07405606Phase 2
• Smoking Harm Reduction Using E-cigarettes and CytisineNot yet recruitingNCT07274475Not applicable
• Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant DepressionRecruitingNCT07211438Phase 2
• Efficacy of an EMDR App for PTSD and SUDRecruitingNCT07146633Not applicable
• Do Antipsychotics Block Insulin Action in the Brain: is it a Class Effect?RecruitingNCT07109245Phase 4
• THC Titration of High-Potency Cannabis ConcentratesRecruitingNCT07105449Not applicable
• Theta-Burst Stimulation to Treat DepressionRecruitingNCT07033780Phase 1
• Talking for Change: Secondary Prevention of Child Sexual Abuse PerpetrationRecruitingNCT07001735Not applicable
• HABITS Study (Helping Addiction by Individualized Therapeutic Stimulation): Pilot Trial of Deep Brain Stimulation Guided By Stereoelectroencephalography for Treatment-Refractory Substance Use DisordersRecruitingNCT06973512Not applicable
• Brain-Oscillation Synchronized Stimulation of the DMPFCRecruitingNCT06942559Not applicable
• Digital Dialectical Behavioural Therapy (d-DBT) for Youth at Clinical High Risk (CHR) for PsychosisRecruitingNCT06928935Not applicable
• The Use of tDCS for Vaping ReductionRecruitingNCT06885606Not applicable
• Accelerated vs. Conventional Theta Burst Stimulation for Late-life DepressionRecruitingNCT06854367Not applicable
• Technology-Enabled Collaborative Care for Young Adults with Type 1 Diabetes and Diabetes Distress: a Feasibility TrialRecruitingNCT06804694Not applicable
• tDCS Plus Varenicline for Smoking CessationRecruitingNCT06798324Phase 4
• TACS to Engage Theta-Gamma Coupling and Enhance Working Memory in Patients With MCI (tACS-MCI)RecruitingNCT06783283Not applicable
• Validating the On-line Creyos Cognitive Assessment Platform in Older Adults With Major Depressive Disorder or Mild Cognitive ImpairmentRecruitingNCT06780917
• Nature-based Virtual Reality Intervention for Depression in Alzheimer's DiseaseRecruitingNCT06732128Not applicable
• Brief Psychological Intervention for Suicidal Patients With Borderline Personality Disorder in the Emergency DepartmentEnrolling by invitationNCT06675461Not applicable
• Magnetic Seizure Therapy for Schizophrenia - TrialRecruitingNCT06672588Not applicable
• Transcranial Magnetic Stimulation for Nicotine Dependence: An Effectiveness-Implementation TrialRecruitingNCT06534047Phase 4
• Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND)RecruitingNCT06518720Phase 2
• Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)RecruitingNCT06512220Phase 2
• rTMS to Improve Motor Function in AutismRecruitingNCT06497920Not applicable
• Matching Assessment and Treatment for Children With Disruptive Behaviour and Their ParentsRecruitingNCT06373484Not applicable
• Theta-Burst Stimulation for Bipolar DepressionRecruitingNCT06370988Not applicable
• Implementation of Transcranial Magnetic Stimulation for Smoking CessationRecruitingNCT06346028Phase 4
• Cognitive Dysfunction in the Addictions Study - Project 4 (P4)RecruitingNCT06299787Not applicable
• Presynaptic Imaging in Major Depressive Episodes After COVID-19RecruitingNCT06086366
• Repetitive Transcranial Magnetic Stimulation for Cannabis Use DisorderRecruitingNCT05859347Not applicable
• Phenotyping Patients With Alcohol and Cannabis Use Disorders Using the Addictions Neuroclinical AssessmentRecruitingNCT05855668Not applicable
• Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual DisabilityRecruitingNCT05744479Phase 4
• Pragmatic Patient-oriented Extension Study of Dialectical Behavior Therapy Booster Sessions for Youth With and/or at Familial Risk for Bipolar DisorderRecruitingNCT05627492Not applicable
• E-field Guided iTBS for Treatment Resistant DepressionRecruitingNCT05583747Not applicable
• Combined and Separate Effects of Cannabis and Tobacco: Psychomotor, Subjective and Physiological OutcomesRecruitingNCT05526196Not applicable
• Smoking Cessation and Menstrual Cycle PhaseRecruitingNCT05515354Phase 4
• ACT for Methamphetamine Use Disorder in Women and Gender Non-Conforming IndividualsNot yet recruitingNCT05334914Not applicable
• Dialectical Behavior Therapy for Youth With and/or at Familial Risk for Bipolar DisorderRecruitingNCT05153382Not applicable
• Three-level Model of DBT-informed Care for Youth With and/or at Familial Risk for Bipolar Disorder (DB3)RecruitingNCT05153369Not applicable
• Effects of NAC on Symptoms of CHR PatientsRecruitingNCT05142735Not applicable
• Effectiveness of an Integrated Care Pathway for Depression: Cluster Randomized Controlled TrialRecruitingNCT05142683Not applicable
• rTMS for Depression in Young Adults With AutismRecruitingNCT04972136Not applicable
• Extended Effects of Cannabis Abstinence on Clinical Symptoms and Cognition in DepressionRecruitingNCT04935619Not applicable
• "Extended" (Alternate Day) Antipsychotic DosingRecruitingNCT04478838Phase 4
• Perceptual Abnormalities and Their Malleability in BDDRecruitingNCT04373629Not applicable
• Age Differences in the Effects of Cannabis on Simulated DrivingRecruitingNCT04325958Not applicable
• Switching From Twice-Daily to Once-Daily Clozapine Dosing in SchizophreniaRecruitingNCT02639702Phase 4
• Helping People Adhere to Their Varenicline Treatment by Co-creating a Conversational Agent: A Feasibility StudyCompletedNCT05997901Not applicableResults posted
• PrEP and Alcohol - Enhancing HIV Pre-Exposure Prophylaxis (PrEP)CompletedNCT05097430Not applicableResults posted
• The Context of Gambling Treatment: Towards Creating an Online Service to Reduce Problem Gambling - Part FiveCompletedNCT05084885Not applicableResults posted
• Remote Treatment of Alcohol WithdrawalCompletedNCT04858490Not applicableResults posted
• A Pilot Trial of Nabilone for the Treatment of ObesityTerminatedNCT04801641Phase 2Results posted
• Examining a Digital Health Approach for Advancing Schizophrenia Illness Self-management and Provider EngagementCompletedNCT04602741Not applicableResults posted
• A Study of Cognitive Adaptation Training in Inpatient Forensic EnvironmentsCompletedNCT04294719Results posted
• Vivitrol Treatment for Cannabis Use DisorderTerminatedNCT04139668Phase 2Results posted
• Deep rTMS and Varenicline for Smoking CessationCompletedNCT04083144Not applicableResults posted
• Feasibility and Outcomes of a Digital Health Support for the Schizophrenia SpectrumCompletedNCT03649815Early Phase 1Results posted
• Generating Evidence for a Support Package to Stabilize Youth Trajectories Out of HomelessnessCompletedNCT03277794Not applicableResults posted
• Combined Alcohol and Cannabis Effects on Skills of Young DriversCompletedNCT03106363Not applicableResults posted
• Testing the Effectiveness of The Welcome Basket InterventionCompletedNCT02946255Not applicableResults posted
• Xyrem and Brain Dopamine in NarcolepsyCompletedNCT02637076Phase 4Results posted
• D1 and D2 Dopamine Receptors in Gambling and Amphetamine ReinforcementCompletedNCT02203786Phase 2Results posted
• The Effects of Prazosin on Dopamine in Healthy Humans: A PET Pilot StudyCompletedNCT01999530Phase 1Results posted
• Initial Screening of Gemfibrozil as a Novel Treatment for Tobacco AddictionCompletedNCT01876810Phase 2Results posted
• The Family Cognitive Adaptation Training Manual: A Test of EffectivenessCompletedNCT01768000Not applicableResults posted
• Fixed or Self-Titrated Dosages of Sativex on Cannabis UsersCompletedNCT01748799Not applicableResults posted
• Sativex and Behavioral-relapse Prevention Strategy in Cannabis DependenceCompletedNCT01747850Phase 2Results posted
• Testing Resources: Manual and Webinar Guided Treatment vs. Manual Guided TreatmentCompletedNCT01743092Not applicableResults posted
• Cannabis Effects on Driving-related Skills of Young DriversCompletedNCT01592409Not applicableResults posted
• Effectiveness of Cognitive Remediation in a Supported Education SettingCompletedNCT01492439Not applicableResults posted
• Distribution of Bupropion and Varenicline to Increase Smoking Cessation AttemptsCompletedNCT01023659Phase 4Results posted
• STOP Study: Effectiveness of Zyban in a Clinical PopulationCompletedNCT01015170Phase 4Results posted
• Phase I Study: Stop Smoking Therapy for Ontario Patients (STOP)CompletedNCT00356993Not applicableResults posted
• Stop Smoking Therapy for Ontario PatientsCompletedNCT00352781Not applicableResults posted
• Smoking While on Transdermal Nicotine Replacement Therapy: Effects on Craving and CessationCompletedNCT00289653Not applicableResults posted
• Addiction Psychoeducation for Canadian MuslimsCompletedNCT07865104Not applicable
• Personalizing Psychosocial Intervention for Children With Disruptive BehaviourCompletedNCT07495683Not applicable
• Development and Evaluation of a Theory and Evidence-based Intervention to Reduce Hazardous Alcohol Consumption Among Treatment Seeking SmokersCompletedNCT07228923Not applicable
• Racial Disparities in Antidepressant Treatment After a Psychiatric ConsultationActive, not recruitingNCT06799078
• Feasibility of a Social-emotional Learning Curriculum in a STEM-based After-school ProgramCompletedNCT06768606Not applicable
• Impact of Spaced iTBS on Plasticity in the Motor CortexCompletedNCT06735794Not applicable
• Psilocybin for Treatment-Resistant Depression in AutismActive, not recruitingNCT06731621Phase 1
• Online Writing Intervention for Major Depressive DisorderCompletedNCT06699719Not applicable
• Narrative Enhancement and Cognitive Therapy for Self-Stigma in YouthCompletedNCT06672562Not applicable
• Feasibility of a Social-emotional Learning Curriculum in an After-school Program for YouthCompletedNCT06619639Not applicable
• Cannabis Edibles and Simulated DrivingCompletedNCT06595576Not applicable
• Evaluating Cannabidiol as a Novel Anticraving Medication for Alcohol Use DisorderActive, not recruitingNCT06512389Phase 2
• Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant OCDCompletedNCT06299319Phase 1
• Investigating the Muscarinic System in Schizophrenia Using Positron Emission TomographyActive, not recruitingNCT06278246
• Effects of Antipsychotics on Brain Insulin Action in FemalesActive, not recruitingNCT06251635Not applicable
• A4i-O: A Platform for Complex Behavioral Health to Address OUDCompletedNCT06215963Not applicable
• Does Psilocybin Change Synaptic Density in Amnestic Mild Cognitive ImpairmentCompletedNCT06041152Phase 2
• The Effects of Non-invasive Neuromodulation on Illness Awareness in SchizophreniaTerminatedNCT05957484Not applicable
• Improving Cognition of Older Adults in Community HousingActive, not recruitingNCT05932342Not applicable
• Digital Human-Based Brief Interventions for Harmful Alcohol Use: The PAHOLA ProjectWithdrawnNCT05906979Not applicable
• Investigating the Effects of Nabilone on Endocannabinoid MetabolismCompletedNCT05885685Phase 4

← Centre for Addiction and Mental Health overview and focus areas